These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27925848)

  • 1. Hospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014: Which was the impact of universal pneumococcal pediatric vaccination?
    Boccalini S; Varone O; Chellini M; Pieri L; Sala A; Berardi C; Bonanni P; Bechini A
    Hum Vaccin Immunother; 2017 Feb; 13(2):428-434. PubMed ID: 27925848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy.
    Boccalini S; Bechini A; Levi M; Tiscione E; Gasparini R; Bonanni P
    Hum Vaccin Immunother; 2013 Mar; 9(3):699-706. PubMed ID: 23295824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy.
    Ansaldi F; Sticchi L; Durando P; Carloni R; Oreste P; Vercelli M; Crovari P; Icardi G
    J Int Med Res; 2008; 36(6):1255-60. PubMed ID: 19094434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
    Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
    Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of second generation pneumococcal conjugate vaccines in Norway.
    Robberstad B; Frostad CR; Akselsen PE; Kværner KJ; Berstad AK
    Vaccine; 2011 Nov; 29(47):8564-74. PubMed ID: 21945264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland.
    Blank PR; Szucs TD
    Vaccine; 2012 Jun; 30(28):4267-75. PubMed ID: 22521287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy.
    Boccalini S; Azzari C; Resti M; Valleriani C; Cortimiglia M; Tiscione E; Bechini A; Bonanni P
    Vaccine; 2011 Nov; 29(51):9521-8. PubMed ID: 22008820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of the heptavalent pneumococcal vaccine against meningitis, pneumonia and acute otitis media in pediatric age. Theoretical coverage offered by the heptavalent conjugate vaccine in Italy].
    Principi N; Esposito S
    Ann Ig; 2002; 14(6 Suppl 7):21-30. PubMed ID: 12638361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.
    Lindstrand A; Bennet R; Galanis I; Blennow M; Ask LS; Dennison SH; Rinder MR; Eriksson M; Henriques-Normark B; Ortqvist A; Alfvén T
    Pediatrics; 2014 Dec; 134(6):e1528-36. PubMed ID: 25384486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis.
    Andrade AL; Afonso ET; Minamisava R; Bierrenbach AL; Cristo EB; Morais-Neto OL; Policena GM; Domingues CMAS; Toscano CM
    PLoS One; 2017; 12(9):e0184204. PubMed ID: 28880953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalized children with pneumonia in Uruguay: pre and post introduction of 7 and 13-valent pneumococcal conjugated vaccines into the National Immunization Program.
    Hortal M; Estevan M; Laurani H; Iraola I; Meny M;
    Vaccine; 2012 Jul; 30(33):4934-8. PubMed ID: 22664222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.
    Esposito S; Principi N;
    Future Microbiol; 2015; 10(10):1599-607. PubMed ID: 26439470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay.
    Pírez MC; Algorta G; Cedrés A; Sobrero H; Varela A; Giachetto G; Montano A
    Pediatr Infect Dis J; 2011 Aug; 30(8):669-74. PubMed ID: 21407145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality.
    Harboe ZB; Dalby T; Weinberger DM; Benfield T; Mølbak K; Slotved HC; Suppli CH; Konradsen HB; Valentiner-Branth P
    Clin Infect Dis; 2014 Oct; 59(8):1066-73. PubMed ID: 25034421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the effect of conjugate vaccines in pneumococcal disease: cohort or population models?
    Standaert B; Demarteau N; Talbird S; Mauskopf J
    Vaccine; 2010 Nov; 28 Suppl 6():G30-8. PubMed ID: 21075268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.